Found: 6
Select item for more details and to access through your institution.
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide.
- Published in:
- British Journal of Pharmacology, 1999, v. 127, n. 4, p. 853, doi. 10.1038/sj.bjp.0702596
- By:
- Publication type:
- Article
Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia.
- Published in:
- Journal of Infectious Diseases, 2003, v. 187, n. 4, p. 631, doi. 10.1086/367990
- By:
- Publication type:
- Article
The TLR4 antagonist Eritoran protects mice from lethal influenza infection.
- Published in:
- Nature, 2013, v. 497, n. 7450, p. 498, doi. 10.1038/nature12118
- By:
- Publication type:
- Article
Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men.
- Published in:
- Innate Immunity, 2012, v. 18, n. 6, p. 793, doi. 10.1177/1753425912441845
- By:
- Publication type:
- Article
Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers.
- Published in:
- Innate Immunity, 2008, v. 14, n. 6, p. 383, doi. 10.1177/1753425908099173
- By:
- Publication type:
- Article
Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue.
- Published in:
- Innate Immunity, 2002, v. 8, n. 6, p. 483, doi. 10.1177/09680519020080060601
- By:
- Publication type:
- Article